Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355270) titled 'A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)' on Jan. 20.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Aqua Medical, Inc.
Condition:
Type-2 Diabetes Mellitus
Intervention:
Device: RF Vapor Ablation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2026
Target Sample ...